Prognostic Value of Serum Neutrophil Gelatinase-Associated Lipocalin in Metastatic and Nonmetastatic Colorectal Cancer

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

NGAL is a Precocious Marker of Therapeutic Response

(2011) Valeria Cernaro et al.   CURRENT PHARMACEUTICAL DESIGN

Perspectives on Current Tumor-Node-Metastasis (TNM) Staging of Cancers of the Colon and Rectum

(2011) Huankai Hu et al.   SEMINARS IN ONCOLOGY

Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy

(2010) L. Landrø et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The Long-term Results of a Randomized Clinical Trial of Laparoscopy-assisted Versus Open Surgery for Colon Cancer

(2009) Antonio M. Lacy et al.   ANNALS OF SURGERY

Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: A new protein enters the scene

(2009) Davide Bolignano et al.   CANCER LETTERS

Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: A single-center analysis

(2009) Josep Martí et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The Implications of Colorectal Cancer Molecular Biology in Clinical Practice

(2008) Hamed Kargozaran et al.   Surgical Oncology Clinics of North America